{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:08:58Z","timestamp":1783354138715,"version":"3.54.6"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T00:00:00Z","timestamp":1591401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00384-020-03658-z","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T01:02:12Z","timestamp":1591405332000},"page":"1397-1412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Is antibiotics use really associated with increased risk of colorectal cancer? An updated systematic review and meta-analysis of observational studies"],"prefix":"10.1007","volume":"35","author":[{"given":"Guangbo","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-3164","authenticated-orcid":false,"given":"Chenyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Patrick","family":"Uy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn J.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandur","family":"Bhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqin","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,6]]},"reference":[{"key":"3658_CR1","unstructured":"World Health Organization (WHO) (2015) Cancer."},{"key":"3658_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/521S1a","volume":"521","author":"H Brody","year":"2015","unstructured":"Brody H (2015) Colorectal cancer. Nature 521:S1","journal-title":"Nature"},{"key":"3658_CR3","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","volume":"392","author":"KJ Foreman","year":"2018","unstructured":"Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, Pletcher MA, Smith AE, Tang K, Yuan CW, Brown JC, Friedman J, He J, Heuton KR, Holmberg M, Patel DJ, Reidy P, Carter A, Cercy K, Chapin A, Douwes-Schultz D, Frank T, Goettsch F, Liu PY, Nandakumar V, Reitsma MB, Reuter V, Sadat N, Sorensen RJD, Srinivasan V, Updike RL, York H, Lopez AD, Lozano R, Lim SS, Mokdad AH, Vollset SE, Murray CJL (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories. Lancet 392:2052\u20132090","journal-title":"Lancet"},{"key":"3658_CR4","doi-asserted-by":"publisher","first-page":"15065","DOI":"10.1038\/nrdp.2015.65","volume":"1","author":"EJ Kuipers","year":"2015","unstructured":"Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJH, Watanabe T (2015) Colorectal cancer. Nat Rev Dis Primers 1:15065","journal-title":"Nat Rev Dis Primers"},{"key":"3658_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","volume":"14","author":"LX Yu","year":"2017","unstructured":"Yu LX, Schwabe RF (2017) The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 14:527\u2013539","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"3658_CR6","doi-asserted-by":"publisher","first-page":"E1310","DOI":"10.3390\/ijms18061310","volume":"18","author":"C Lucas","year":"2017","unstructured":"Lucas C, Barnich N, Nguyen HTT (2017) Microbiota, inflammation and colorectal cancer. Int J Mol Sci 18:E1310","journal-title":"Int J Mol Sci"},{"key":"3658_CR7","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10096-016-2881-8","volume":"36","author":"R Gao","year":"2017","unstructured":"Gao R, Gao Z, Huang L, Qin H (2017) Gut microbiota and colorectal cancer. Eur J Clin Microbiol Infect Dis 36:757\u2013769","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3658_CR8","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.mib.2015.07.007","volume":"27","author":"MK Gibson","year":"2015","unstructured":"Gibson MK, Crofts TS, Dantas G (2015) Antibiotics and the developing infant gut microbiota and resistome. Curr Opin Microbiol 27:51\u201356","journal-title":"Curr Opin Microbiol"},{"key":"3658_CR9","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1136\/gutjnl-2016-312297","volume":"65","author":"G Ianiro","year":"2016","unstructured":"Ianiro G, Tilg H, Gasbarrini A (2016) Antibiotics as deep modulators of gut microbiota: between good and evil. Gut 65:1906\u20131915","journal-title":"Gut"},{"key":"3658_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1126\/science.aad9382","volume":"352","author":"EG Pamer","year":"2016","unstructured":"Pamer EG (2016) Resurrecting the intestinal microbiota to combat antibiotic-resistant pathogens. Science 352:535\u2013538","journal-title":"Science"},{"key":"3658_CR11","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1002\/ijc.28738","volume":"135","author":"JL Wang","year":"2014","unstructured":"Wang JL, Chang CH, Lin JW, Wu LC, Chuang LM, Lai MS (2014) Infection, antibiotic therapy and risk of colorectal cancer: a nationwide nested case-control study in patients with Type 2 diabetes mellitus. Int J Cancer 135:956\u2013967","journal-title":"Int J Cancer"},{"key":"3658_CR12","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s10620-015-3828-0","volume":"61","author":"VK Dik","year":"2016","unstructured":"Dik VK, van Oijen MG, Smeets HM, Siersema PD (2016) Frequent use of antibiotics is associated with colorectal cancer risk: results of a nested case-control study. Dig Dis Sci 61:255\u2013264","journal-title":"Dig Dis Sci"},{"key":"3658_CR13","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1136\/gutjnl-2019-318593","volume":"68","author":"J Zhang","year":"2019","unstructured":"Zhang J, Haines C, Watson AJM, Hart AR, Platt MJ, Pardoll DM, Cosgrove SE, Gebo KA, Sears CL (2019) Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study. Gut 68:1971\u20131978","journal-title":"Gut"},{"key":"3658_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M et al (2015) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1","journal-title":"Syst Rev"},{"key":"3658_CR15","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al (2017) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp (accessed May 17, 2017)."},{"key":"3658_CR16","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"3658_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"3658_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/pds.3765","volume":"24","author":"B Boursi","year":"2015","unstructured":"Boursi B, Haynes K, Mamtani R, Yang YX (2015) Impact of antibiotic exposure on the risk of colorectal cancer. Pharmacoepidemiol Drug Saf 24:534\u2013542","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3658_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10549-005-2115-8","volume":"92","author":"RC Didham","year":"2005","unstructured":"Didham RC, Reith DM, McConnell DW, Harrison KS (2005) Antibiotic exposure and breast cancer in New Zealand. Breast Cancer Res Treat 92:163\u2013167","journal-title":"Breast Cancer Res Treat"},{"key":"3658_CR20","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1002\/ijc.23622","volume":"123","author":"A Kilkkinen","year":"2008","unstructured":"Kilkkinen A, Rissanen H, Klaukka T, Pukkala E, Heli\u00f6vaara M, Huovinen P, M\u00e4nnist\u00f6 S, Aromaa A, Knekt P (2008) Antibiotic use predicts an increased risk of cancer. Int J Cancer 123:2152\u20132155","journal-title":"Int J Cancer"},{"key":"3658_CR21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41416-019-0701-5","volume":"122","author":"D Armstrong","year":"2020","unstructured":"Armstrong D, Dregan A, Ashworth M, White P, McGee C, de Lusignan S (2020) The association between colorectal cancer and prior antibiotic prescriptions: case control study. Br J Cancer 122:912\u2013917. https:\/\/doi.org\/10.1038\/s41416-019-0701-5","journal-title":"Br J Cancer"},{"key":"3658_CR22","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1086\/516306","volume":"26","author":"ME Falagas","year":"1998","unstructured":"Falagas ME, Walker AM, Jick H, Ruthazer R, Griffith J, Snydman DR (1998) Late incidence of cancer after metronidazole use: a matched metronidazole user\/nonuser study. Clin Infect Dis 26:384\u2013388","journal-title":"Clin Infect Dis"},{"key":"3658_CR23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1099-1557(199803\/04)7:2<99::AID-PDS320>3.0.CO;2-0","volume":"7","author":"GD Friedman","year":"1998","unstructured":"Friedman GD, Coates AO, Potter JD, Slattery ML (1998) Drugs and colon cancer. Pharmacoepidemiol Drug Saf 7:99\u2013106","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"3658_CR24","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1002\/ijc.24545","volume":"125","author":"GD Friedman","year":"2009","unstructured":"Friedman GD, Jiang SF, Udaltsova N, Quesenberry CP Jr, Chan J, Habel LA (2009) Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity. Int J Cancer 125:2173\u20132178","journal-title":"Int J Cancer"},{"key":"3658_CR25","doi-asserted-by":"publisher","first-page":"E1174","DOI":"10.3390\/cancers11081174","volume":"11","author":"F Petrelli","year":"2019","unstructured":"Petrelli F, Ghidini M, Ghidini A, Perego G, Cabiddu M, Khakoo S et al (2019) Use of antibiotics and risk of cancer: a systematic review and meta-analysis of observational studies. Cancers (Basel) 11:E1174","journal-title":"Cancers (Basel)"},{"key":"3658_CR26","doi-asserted-by":"publisher","first-page":"gutjnl-2020-320","DOI":"10.1136\/gutjnl-2020-320826","volume":"2020","author":"QY Wan","year":"2020","unstructured":"Wan QY, Zhao R, Wang Y, Wu Y, Wu XT (2020) Antibiotic use and risk of colorectal cancer: a meta-analysis of 412 450 participants. Gut 2020. [Epub ahead of print]:gutjnl-2020-320826. https:\/\/doi.org\/10.1136\/gutjnl-2020-320826","journal-title":"Gut"},{"key":"3658_CR27","doi-asserted-by":"publisher","unstructured":"Sanyaolu LN, Oakley NJ, Nurmatov U, Dolwani S, Ahmed H (2019) Antibiotic exposure and the risk of colorectal adenoma and carcinoma: a systematic review and meta-analysis of observational studies. Colorectal Dis 2019. https:\/\/doi.org\/10.1111\/codi.14921","DOI":"10.1111\/codi.14921"},{"key":"3658_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.mib.2013.03.009","volume":"16","author":"A Khosravi","year":"2013","unstructured":"Khosravi A, Mazmanian SK (2013) Disruption of the gut microbiome as a risk factor for microbial infections. Curr Opin Microbiol 16:221\u2013227","journal-title":"Curr Opin Microbiol"},{"key":"3658_CR29","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","volume":"33","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Helmink BA, Spencer CN, Reuben A, Wargo JA (2018) The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell 33:570\u2013580","journal-title":"Cancer Cell"},{"key":"3658_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","volume":"535","author":"K Honda","year":"2016","unstructured":"Honda K, Littman DR (2016) The microbiota in adaptive immune homeostasis and disease. Nature 535:75\u201384","journal-title":"Nature"},{"key":"3658_CR31","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.chom.2017.10.020","volume":"22","author":"JH Yang","year":"2017","unstructured":"Yang JH, Bhargava P, McCloskey D, Mao N, Palsson BO, Collins JJ (2017) Antibiotic-induced changes to the host metabolic environment inhibit drug efficacy and alter immune function. Cell Host Microbe 22:757\u2013765","journal-title":"Cell Host Microbe"},{"key":"3658_CR32","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nrmicro2974","volume":"11","author":"F Sommer","year":"2013","unstructured":"Sommer F, B\u00e4ckhed F (2013) The gut microbiota--masters of host development and physiology. Nat Rev Microbiol 11:227\u2013238","journal-title":"Nat Rev Microbiol"},{"key":"3658_CR33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-016-0294-z","volume":"8","author":"A Langdon","year":"2016","unstructured":"Langdon A, Crook N, Dantas G (2016) The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation. Genome Med 8:39","journal-title":"Genome Med"},{"key":"3658_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1128\/AAC.00306-08","volume":"53","author":"K Saxton","year":"2009","unstructured":"Saxton K, Baines SD, Freeman J, O\u2019Connor R, Wilcox MH (2009) Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model. Antimicrob Agents Chemother 53:412\u2013420","journal-title":"Antimicrob Agents Chemother"},{"key":"3658_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0089417","volume":"9","author":"H Knecht","year":"2014","unstructured":"Knecht H, Neulinger SC, Heinsen FA, Knecht C, Schilhabel A, Schmitz RA, Zimmermann A, dos Santos VM, Ferrer M, Rosenstiel PC, Schreiber S, Friedrichs AK, Ott SJ (2014) Effects of \u03b2-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea. PLoS One 9:e89417","journal-title":"PLoS One"},{"key":"3658_CR36","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1038\/ctg.2016.53","volume":"7","author":"K Mima","year":"2016","unstructured":"Mima K, Cao Y, Chan AT, Qian ZR, Nowak JA, Masugi Y, Shi Y, Song M, da Silva A, Gu M, Li W, Hamada T, Kosumi K, Hanyuda A, Liu L, Kostic AD, Giannakis M, Bullman S, Brennan CA, Milner DA, Baba H, Garraway LA, Meyerhardt JA, Garrett WS, Huttenhower C, Meyerson M, Giovannucci EL, Fuchs CS, Nishihara R, Ogino S (2016) Fusobacterium nucleatum in Colorectal carcinoma tissue according to tumor location. Clin Transl Gastroenterol 7:e200","journal-title":"Clin Transl Gastroenterol"},{"key":"3658_CR37","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.2174\/1381612822666160715115025","volume":"22","author":"PN Batalha","year":"2016","unstructured":"Batalha PN, Vieira de Souza MC, Pe\u00f1a-Cabrera E, Cruz DC, da Costa Santos Boechat F (2016) Quinolones in the search for new anticancer agents. Curr Pharm Des 22:6009\u20136020","journal-title":"Curr Pharm Des"},{"key":"3658_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejmech.2019.01.017","volume":"165","author":"F Gao","year":"2019","unstructured":"Gao F, Zhang X, Wang T, Xiao J (2019) Quinolone hybrids and their anti-cancer activities: An overview. Eur J Med Chem 165:59\u201379","journal-title":"Eur J Med Chem"},{"key":"3658_CR39","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/sj.bjc.6600079","volume":"86","author":"C Herold","year":"2002","unstructured":"Herold C, Ocker M, Ganslmayer M, Gerauer H, Hahn EG, Schuppan D (2002) Ciprofloxacin induces apoptosis and inhibits proliferation of human colorectal carcinoma cells. Br J Cancer 86:443\u2013448","journal-title":"Br J Cancer"},{"key":"3658_CR40","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11523-019-00638-4","volume":"14","author":"F Liu","year":"2019","unstructured":"Liu F, Knight T, Su Y, Edwards H, Wang G, Wang Y, Taub JW, Lin H, Sun L, Ge Y (2019) Venetoclax Synergistically enhances the anti-leukemic activity of vosaroxin against acute myeloid leukemia cells ex vivo. Target Oncol 14:351\u2013364","journal-title":"Target Oncol"},{"key":"3658_CR41","doi-asserted-by":"publisher","first-page":"e514","DOI":"10.3324\/haematol.2018.191361","volume":"103","author":"F Ravandi","year":"2018","unstructured":"Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Pigneux A, Horst HA, R\u00e9cher C, Klimek VM, Cortes JE, Carella AM, Egyed M, Krug U, Fox JA, Craig AR, Ward R, Smith JA, Acton G, Kantarjian HM, Stuart RK (2018) Phase 3 results for vosaroxin\/cytarabine in the subset of patients \u226560 years old with refractory\/early relapsed acute myeloid leukemia. Haematologica 103:e514\u2013e518","journal-title":"Haematologica"},{"key":"3658_CR42","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1007\/s40265-016-0614-z","volume":"76","author":"GC Jamieson","year":"2016","unstructured":"Jamieson GC, Fox JA, Poi M, Strickland SA (2016) Molecular and pharmacologic properties of the anticancer quinolone derivative vosaroxin: a new therapeutic agent for acute myeloid leukemia. Drugs 76:1245\u20131255","journal-title":"Drugs"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03658-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-020-03658-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-020-03658-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T23:28:16Z","timestamp":1622935696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-020-03658-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,6]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["3658"],"URL":"https:\/\/doi.org\/10.1007\/s00384-020-03658-z","relation":{},"ISSN":["0179-1958","1432-1262"],"issn-type":[{"value":"0179-1958","type":"print"},{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,6]]},"assertion":[{"value":"25 May 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This systematic review and meta-analysis used previously published data and did not use any unpublished data. Therefore, ethical approval for analysis was not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}